A |
2024-05-21 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
2167.0000 |
2167.0000 |
2 |
0001055726 |
Restricted Stock Unit |
A |
2024-05-21 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
2917.0000 |
2917.0000 |
1 |
0001055726 |
Common Stock Options |
D |
2024-05-15 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
2166.0000 |
0.0000 |
2 |
0001055726 |
Restricted Stock Unit |
A |
2024-05-15 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
2166.0000 |
7710.0000 |
1 |
0001055726 |
Common Stock |
D |
2023-05-16 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
19000.0000 |
0.0000 |
2 |
0001055726 |
Restricted Stock Unit |
A |
2023-05-16 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
19000.0000 |
66534.0000 |
1 |
0001055726 |
Common Stock |
A |
2023-05-15 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
26000.0000 |
26000.0000 |
4 |
0001055726 |
Restricted Stock Unit |
A |
2023-05-15 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
35000.0000 |
35000.0000 |
3 |
0001055726 |
Common Stock Options |
A |
2022-05-16 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
19000.0000 |
19000.0000 |
3 |
0001055726 |
Restricted Stock Unit |
A |
2022-05-16 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
28000.0000 |
28000.0000 |
4 |
0001055726 |
Common Stock Options |
D |
2022-05-13 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
18000.0000 |
0.0000 |
2 |
0001055726 |
Restricted Stock Unit |
A |
2022-05-13 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
18000.0000 |
47534.0000 |
1 |
0001055726 |
Common Stock |
D |
2022-03-21 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
4273.0000 |
0.0000 |
2 |
0001055726 |
Restricted Stock Unit |
A |
2022-03-21 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
4273.0000 |
29534.0000 |
1 |
0001055726 |
Common Stock |
A |
2021-06-15 |
|
PUMA BIOTECHNOLOGY, INC. |
4 |
A-Award |
--D |
27858.0000 |
40732.0000 |
1 |
0001401667 |
COMMON STOCK |
D |
2021-06-10 |
|
PUMA BIOTECHNOLOGY, INC. |
4 |
S-Sale |
--D |
12874.0000 |
12874.0000 |
1 |
0001401667 |
COMMON STOCK |
A |
2021-06-03 |
|
Allena Pharmaceuticals, Inc. |
4 |
A-Award |
--D |
37000.0000 |
37000.0000 |
1 |
0001624658 |
Stock Option (Right to Buy) |
A |
2021-05-14 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
8700.0000 |
25261.0000 |
1 |
0001055726 |
Common Stock |
D |
2021-05-14 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
8700.0000 |
0.0000 |
4 |
0001055726 |
Restricted Stock Unit |
A |
2021-05-13 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
27000.0000 |
27000.0000 |
2 |
0001055726 |
Common Stock Options |
A |
2021-05-13 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
18000.0000 |
18000.0000 |
3 |
0001055726 |
Restricted Stock Unit |
D |
2021-03-21 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
4274.0000 |
4273.0000 |
2 |
0001055726 |
Restricted Stock Unit |
A |
2021-03-21 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
4274.0000 |
16561.0000 |
1 |
0001055726 |
Common Stock |
A |
2020-10-05 |
|
Allena Pharmaceuticals, Inc. |
4 |
A-Award |
--D |
28000.0000 |
28000.0000 |
1 |
0001624658 |
Stock Option (Right to Buy) |
A |
2020-06-09 |
|
PUMA BIOTECHNOLOGY, INC. |
4 |
A-Award |
--D |
25748.0000 |
25748.0000 |
1 |
0001401667 |
COMMON STOCK |
A |
2020-05-14 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
8700.0000 |
8700.0000 |
2 |
0001055726 |
Restricted Stock Unit |
A |
2020-05-14 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
13300.0000 |
13300.0000 |
1 |
0001055726 |
Common Stock Options |
D |
2020-05-08 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
8013.0000 |
0.0000 |
2 |
0001055726 |
Restricted Stock Unit |
A |
2020-05-08 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
8013.0000 |
12287.0000 |
1 |
0001055726 |
Common Stock |
D |
2020-03-21 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
4274.0000 |
8547.0000 |
2 |
0001055726 |
Restricted Stock Unit |
A |
2020-03-21 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
M-Exempt |
--D |
4274.0000 |
4274.0000 |
1 |
0001055726 |
Common Stock |
A |
2019-11-12 |
|
PUMA BIOTECHNOLOGY, INC. |
4 |
A-Award |
--D |
125306.0000 |
125306.0000 |
1 |
0001401667 |
Stock Option (Right to Buy) |
A |
2019-05-08 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
12500.0000 |
12500.0000 |
1 |
0001055726 |
Common Stock Options |
A |
2019-05-08 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
8013.0000 |
8013.0000 |
2 |
0001055726 |
Restricted Stock Unit |
A |
2019-03-21 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
12821.0000 |
12821.0000 |
1 |
0001055726 |
Restricted Stock Unit |
A |
2019-03-21 |
|
INOVIO PHARMACEUTICALS, INC. |
4 |
A-Award |
--D |
20000.0000 |
20000.0000 |
2 |
0001055726 |
Common Stock Option |
- |
- |
|
PUMA BIOTECHNOLOGY, INC. |
3 |
- |
--- |
|
|
1 |
- |
- |
- |
- |
|
Allena Pharmaceuticals, Inc. |
3 |
- |
--- |
|
|
1 |
- |
- |
- |
- |
|
INOVIO PHARMACEUTICALS, INC. |
3 |
- |
--- |
|
|
1 |
- |
- |